Viking Therapeutics Inc (VKTX)

[DMOST]

Viking should not sell themselves / Us out cheaply with this offering.

Viking Therapeutics Announces Proposed Public Offering of Common Stock
https://finance.yahoo.com/news/viking-therapeutics-announces-proposed-public-202100958.html

It doesn't really say that in the above article, but in the prospectus itself, they do note the closing price on September 18 of $19.46.

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
https://ih.advfn.com/p.php?pid=nmona&article=78293005

" We are offering shares of our common stock in this offering.

Our common stock is listed on the Nasdaq Capital Market under the symbol “VKTX.” On September 18, 2018, the closing price of our common stock on the Nasdaq Capital Market was $19.46 per share. "

Hence the subsequent fall late in trading as some had advance notice of the pending PR, which came after the bell.

Viking (VKTX) $22 median high on yesterday should, at the least, be priced at 1/4 of what Madrigal (MDGL)is at this time $224 median high on yesterday.

Viking Therapeutics, Inc. (VKTX) $56 a share, on the high end, and $39 a share on the low end, should be its price. Particularly sense it has a NASH drug better or equal to Madrigal Pharmaceuticals Inc (MDGL) $330 a share once on the high end, and now $224. MDGL also did a offer with a set price of $303 a share.

Reasoning: VKTX has 4x more shares issued and outstanding and 5.8x more shares in the float 60.66M and 41.82m respectfully versus MDGL 15.37M and 7.21M at last note

https://finance.yahoo.com/quote/VKTX/key-statistics?p=VKTX

Versus

https://finance.yahoo.com/quote/MDGL/key-statistics?p=MDGL

VIKING DON'T SELL US DOWN / OUT TOO CHEAPLY.

GO VKTX

"PEACE"

Note: the amount of shares and the price per share has not officially been listed yet.